Raymond James Financial Services Advisors »

Apogee Therapeutics shares owned by Raymond James Financial Services Advisors

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Raymond James Financial Services Advisors from 13F filings

Historical chart of Raymond James Financial Services Advisors investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Raymond James Financial Services Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Raymond James Financial Services Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $324k 4.9k 66.45

More positions owned by Raymond James Financial Services Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Vanguard Index Fds Value Etf (VTV)
Home Depot (HD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Raymond James Financial Services Advisors

Top funds holding Apogee Therapeutics

VR Adviser
Fairmount Funds Management
RA Capital Management
Perceptive Advisors
Wellington Management Company
OrbiMed Advisors
Vanguard Group
Franklin Resources
T. Rowe Price Associates
Point72 Asset Management
Braidwell
Bank of America Corporation
Henderson Group
Dr. Jeffrey R. Jay, M.D.
Frazier Life Sciences Management

View all funds holding Apogee Therapeutics